N-(2-{5-[(4-tert-butylphenyl)methylidene]-2,4-dioxo-1,3-thiazolidin-3-yl}ethyl)-2-chloroacetamide

Catalog No. :
ACTZZX335
CAS No. :
565195-76-8
Molecular Formula :
C18H21ClN2O3S
Molecular Weight :
380.90

IUPAC Name:(Z)-N-(2-(5-(4-(tert-butyl)benzylidene)-2,4-dioxothiazolidin-3-yl)ethyl)-2-chloroacetamide

N-(2-{5-[(4-tert-butylphenyl)methylidene]-2,4-dioxo-1,3-thiazolidin-3-yl}ethyl)-2-chloroacetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$109.00Login to see priceInquiryInquiry
250mg95%$149.00Login to see priceInquiryInquiry
1g95%$373.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(2-{5-[(4-tert-butylphenyl)methylidene]-2,4-dioxo-1,3-thiazolidin-3-yl}ethyl)-2-chloroacetamide
IUPAC Name(Z)-N-(2-(5-(4-(tert-butyl)benzylidene)-2,4-dioxothiazolidin-3-yl)ethyl)-2-chloroacetamide
MDL No.MFCD06654923
Molecular FormulaC18H21ClN2O3S
Molecular Weight380.90
SMILESCC(C)(C)C1=CC=C(/C=C2\SC(=O)N(CCNC(=O)CCl)C2=O)C=C1
InChI KeyJLYVXFMTJOSSSM-UVTDQMKNSA-N
SynonymAcetamide, 2-chloro-N-[2-[5-[[4-(1,1-dimethylethyl)phenyl]methylene]-2,4-dioxo-3-thiazolidinyl]ethyl]-;N-(2-{5-[(4-tert-butylphenyl)methylidene]-2,4-dioxo-1,3-thiazolidin-3-yl}ethyl)-2-chloroacetamide
CAS No.565195-76-8

Synthetic Route by SureRoute

1. ACTZZX335 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTZZX335 route product structure diagram
    ACTZZX335565195-76-8
Inquiry

2. ACTZZX335 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTZZX335 route product structure diagram
    ACTZZX335565195-76-8
Inquiry

Comments (0)